Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Breast
Study Phase
Phase 3
Study Completion Date
May 2007
NCT00089661Uploaded 09-26-2016
Available for Download
PDS UID: Breast_Amgen_2004_153
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Files:
PROTOCOL20040135 Protocol Amend 3 REDACTED.pdf
CRFAmgen 20040135 CRF REDACTED.pdf
DATA DICTIONARYAmgen 20040135 DDT.pdf
DATA (COMPARATOR ARM)Amgen 20040135 SAS datasets.zip